Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Accurate measurement of androgen after androgen esters: problems created by ex vivo esterase effects and LC-MS/MS interference.

Ceponis J, Swerdloff R, Leung A, Hull L, Bai F, Longstreth J, Dudley R, Danoff T, Wang C.

Andrology. 2019 Jan;7(1):42-52. doi: 10.1111/andr.12554. Epub 2018 Oct 21.

2.

Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial.

Morgentaler A, McGettigan J, Xiang Q, Danoff TM, Gould EM.

Int J Impot Res. 2015 Mar-Apr;27(2):41-5. doi: 10.1038/ijir.2014.28. Epub 2014 Jul 24.

PMID:
25056809
3.

Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.

Thornton P, Silverman LA, Geffner ME, Neely EK, Gould E, Danoff TM.

Pediatr Endocrinol Rev. 2014 Mar;11(3):306-17. Review.

PMID:
24719967
4.

Case fatality and population mortality associated with anaphylaxis in the United States.

Ma L, Danoff TM, Borish L.

J Allergy Clin Immunol. 2014 Apr;133(4):1075-83. doi: 10.1016/j.jaci.2013.10.029. Epub 2013 Dec 14.

5.

Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy.

Neely EK, Silverman LA, Geffner ME, Danoff TM, Gould E, Thornton PS.

Int J Pediatr Endocrinol. 2013 Dec 2;2013(1):20. doi: 10.1186/1687-9856-2013-20.

6.

Renal impairment, hypertension and plasma urotensin II.

Mosenkis A, Kallem RR, Danoff TM, Aiyar N, Bazeley J, Townsend RR.

Nephrol Dial Transplant. 2011 Feb;26(2):609-14. doi: 10.1093/ndt/gfq416. Epub 2010 Jul 9.

7.

Digoxin immune fab treatment for severe preeclampsia.

Adair CD, Buckalew VM, Graves SW, Lam GK, Johnson DD, Saade G, Lewis DF, Robinson C, Danoff TM, Chauhan N, Hopoate-Sitake M, Porter KB, Humphrey RG, Trofatter KF, Amon E, Ward S, Kennedy L, Mason L, Johnston JA.

Am J Perinatol. 2010 Sep;27(8):655-62. doi: 10.1055/s-0030-1249762. Epub 2010 Mar 15.

PMID:
20232280
8.

An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.

Kumar S, Matheny CJ, Hoffman SJ, Marquis RW, Schultz M, Liang X, Vasko JA, Stroup GB, Vaden VR, Haley H, Fox J, DelMar EG, Nemeth EF, Lago AM, Callahan JF, Bhatnagar P, Huffman WF, Gowen M, Yi B, Danoff TM, Fitzpatrick LA.

Bone. 2010 Feb;46(2):534-42. doi: 10.1016/j.bone.2009.09.028. Epub 2009 Sep 26.

PMID:
19786130
9.

Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods.

Pullen MA, Harpel MR, Danoff TM, Brooks DP.

J Immunol Methods. 2008 Jul 31;336(2):235-41. doi: 10.1016/j.jim.2008.05.005. Epub 2008 Jun 4.

PMID:
18555269
10.

The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.

Firmann M, Mayor V, Vidal PM, Bochud M, Pécoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P.

BMC Cardiovasc Disord. 2008 Mar 17;8:6. doi: 10.1186/1471-2261-8-6.

11.

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

Risérus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, Strum JC, Basu S, Cheeseman J, Fielding BA, Humphreys SM, Danoff T, Moore NR, Murgatroyd P, O'Rahilly S, Sutton P, Willson T, Hassall D, Frayn KN, Karpe F.

Diabetes. 2008 Feb;57(2):332-9. Epub 2007 Nov 16.

12.

Ethanol does not alter the pharmacokinetic profile of the controlled-release formulation of carvedilol.

Henderson LS, Tenero DM, Campanile AM, Baidoo CA, Danoff TM.

J Clin Pharmacol. 2007 Nov;47(11):1358-65.

PMID:
17962424
13.

Human urotensin II in the plasma of anephric subjects.

Mosenkis A, Danoff TM, Aiyar N, Bazeley J, Townsend RR.

Nephrol Dial Transplant. 2007 Apr;22(4):1269-70. Epub 2006 Nov 28. No abstract available.

PMID:
17132703
14.

Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.

Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.

Am J Cardiol. 2006 Oct 2;98(7A):17L-26L. Epub 2006 Aug 28.

PMID:
17023228
15.

Pharmacokinetic properties of a new controlled-release formulation of carvedilol.

Tenero DM, Henderson LS, Baidoo CA, Harter AH, Campanile AM, Danoff TM, Boyle D.

Am J Cardiol. 2006 Oct 2;98(7A):5L-16L. Epub 2006 Aug 28. Review.

PMID:
17023227
16.

A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis.

Toomey JR, Abboud MA, Valocik RE, Koster PF, Burns-Kurtis CL, Pillarisetti K, Danoff TM, Erhardt JA.

J Thromb Haemost. 2006 Sep;4(9):1989-96.

18.

Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.

Findling RL, Nucci G, Piergies AA, Gomeni R, Bartolic EI, Fong R, Carpenter DJ, Leeder JS, Gaedigk A, Danoff TM.

Neuropsychopharmacology. 2006 Jun;31(6):1274-85.

19.

CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.

Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM, Holtzman MJ.

Nat Med. 2005 Nov;11(11):1180-7. Epub 2005 Oct 2.

20.

Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function.

Mange KC, Prak EL, Kamoun M, Du Y, Goodman N, Danoff T, Hoy T, Newman M, Joffe MM, Feldman HI.

Kidney Int. 2004 Sep;66(3):1187-92.

21.

Identification of a pharmacogenetic effect by linkage disequilibrium mapping.

Xu CF, Lewis KF, Yeo AJ, McCarthy LC, Maguire MF, Anwar Z, Danoff TM, Roses AD, Purvis IJ.

Pharmacogenomics J. 2004;4(6):374-8.

PMID:
15303110
22.

Pharmacogenetics to predict drug-related adverse events.

Hosford DA, Lai EH, Riley JH, Xu CF, Danoff TM, Roses AD.

Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:9-12. Review.

PMID:
15209398
23.

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.

Danoff TM, Campbell DA, McCarthy LC, Lewis KF, Repasch MH, Saunders AM, Spurr NK, Purvis IJ, Roses AD, Xu CF.

Pharmacogenomics J. 2004;4(1):49-53.

PMID:
14647407
24.

Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG.

J Clin Invest. 2002 Aug;110(3):341-50.

25.

Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.

Tsukahara T, Makino Y, Fujii T, Ogawa M, Saisho H, Hamano Y, Ueda S, Akikusa B, Danoff TM.

Clin Immunol. 2002 Apr;103(1):89-97.

PMID:
11987989
26.

Impaired T cell function in RANTES-deficient mice.

Makino Y, Cook DN, Smithies O, Hwang OY, Neilson EG, Turka LA, Sato H, Wells AD, Danoff TM.

Clin Immunol. 2002 Mar;102(3):302-9.

PMID:
11890717
27.

Beneficial effects of targeting CCR5 in allograft recipients.

Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TM, Hancock WW.

Transplantation. 2001 Oct 15;72(7):1199-205.

PMID:
11602842
28.

Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts.

Iwano M, Fischer A, Okada H, Plieth D, Xue C, Danoff TM, Neilson EG.

Mol Ther. 2001 Feb;3(2):149-59.

29.

Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure.

Ortiz A, Lorz C, Catalán MP, Danoff TM, Yamasaki Y, Egido J, Neilson EG.

Kidney Int. 2000 Mar;57(3):969-81.

30.

Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene.

Okada H, Danoff TM, Fischer A, Lopez-Guisa JM, Strutz F, Neilson EG.

Am J Physiol. 1998 Aug;275(2):F306-14. doi: 10.1152/ajprenal.1998.275.2.F306.

PMID:
9691022
31.

Chemokines in interstitial injury.

Danoff TM.

Kidney Int. 1998 Jun;53(6):1807-8. No abstract available.

33.

Early role of Fsp1 in epithelial-mesenchymal transformation.

Okada H, Danoff TM, Kalluri R, Neilson EG.

Am J Physiol. 1997 Oct;273(4):F563-74. doi: 10.1152/ajprenal.1997.273.4.F563.

PMID:
9362334
34.

Screening for homologous recombination in ES cells using RT-PCR.

Danoff TM, Chiang M, Jänne PA, Neilson EG.

Biotechniques. 1997 Jan;22(1):22-4, 26. No abstract available.

35.

Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.

Ortiz-Arduan A, Danoff TM, Kalluri R, González-Cuadrado S, Karp SL, Elkon K, Egido J, Neilson EG.

Am J Physiol. 1996 Dec;271(6 Pt 2):F1193-201.

PMID:
8997393
36.

Possible pathogenesis of renal fibrosis.

Okada H, Strutz F, Danoff TM, Neilson EG.

Kidney Int Suppl. 1996 May;54:S37-8. Review. No abstract available.

PMID:
8731192
37.

Possible mechanisms of renal fibrosis.

Okada H, Strutz F, Danoff TM, Kalluri R, Neilson EG.

Contrib Nephrol. 1996;118:147-54. Review. No abstract available.

PMID:
8744052
38.

Identification and characterization of a fibroblast marker: FSP1.

Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG.

J Cell Biol. 1995 Jul;130(2):393-405.

39.
40.

Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES.

Danoff TM, Lalley PA, Chang YS, Heeger PS, Neilson EG.

J Immunol. 1994 Feb 1;152(3):1182-9.

PMID:
7507961
41.

Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen.

Neilson EG, Kalluri R, Sun MJ, Gunwar S, Danoff T, Mariyama M, Myers JC, Reeders ST, Hudson BG.

J Biol Chem. 1993 Apr 25;268(12):8402-5.

42.

Epidermal growth factor receptor numbers in male and female mouse primary hepatocyte cultures.

Benveniste R, Danoff TM, Ilekis J, Craig HR.

Cell Biochem Funct. 1988 Oct;6(4):231-5.

PMID:
3191582
43.

Murine sex-limited protein expression requires androgens and pituitary hormones.

Danoff TM, Goldman MB, Goldman JN.

Immunogenetics. 1986;23(1):7-10.

PMID:
3943881

Supplemental Content

Loading ...
Support Center